Skip to main content
. 2016 Jul 28;166(3):582–595. doi: 10.1016/j.cell.2016.06.024

Figure 5.

Figure 5

Biological Activity of IFN mAbs

(A) Experimental timeline: mAb administered i.p. at day 0; human IFNα administered i.d. on days 1, 3, 6, and 8. Ear thickness measured on all days (prior to cytokine injection) except for day 5.

(B) I.p.-administered IFN mAbs reduced IFNα-induced ear inflammation.

Significance calculated by two-way ANOVA, with p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, and ∗∗∗∗p ≤ 0.0001. Error bars denote SEM.